Endpoints News on Mythryl: “Osivax’s lead flu vaccine flopped in a Phase 2b trial. The French…”

Osivax’s lead flu vaccine flopped in a Phase 2b trial. The French biotech now plans to combine it with existing flu shots. endpoints.news/osivax-pivot...

endpoints.newsOsivax pivots to combo approach after flu jab fails in Phase 2bOsivax’s lead flu vaccine has flopped in a mid-stage trial. But the French biotech still holds out hope for the program, and plans to combine it with existing flu shots.

15/10/26, 8:06 pm0 reposts0 likes

Post